Maven Securities’s Labcorp LH Stock Holding History

Maven Securities’s Portfolio LH Stock Details LH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,005	Closed	-$225K	–	940
2024 Q3	$225K	Sell	1,005 -97	-9%	-$21.3K	﹤0.01%	833
2024 Q2	$224K	Sell	1,102 -250	-18%	-$50.9K	0.01%	858
2024 Q1	$295K	Buy	+1,352	New	+$298K	0.02%	275
2023 Q2	–	Sell	-1,559	Closed	-$307K	–	969
2023 Q1	$307K	Buy	+1,559	New	+$321K	0.01%	786

Other funds holding LH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Diamond Hill Capital Management Columbus, Ohio $16B AUM 4.15% 1-Year Est. Return

Maven Securities's LH Position: Q4 2024 in Review

Maven Securities sold out of Labcorp (LH) in Q4 2024, closing a stake of 1,005 shares — an estimated $225K sold.

Maven Securities first reported a position in LH in Q1 2023 and held it in 4 quarters. The position peaked at $307K in Q1 2023. 923 funds tracked by Wall St. Rank hold LH as of Q4 2024.

Maven Securities reported no remaining Labcorp position as of Q4 2024 after selling out during the quarter.
Maven Securities sold 1,005 Labcorp shares in Q4 2024, an estimated $225K.
Maven Securities first reported a position in Labcorp in Q1 2023 and held it in 4 quarters.
Maven Securities's Labcorp position peaked at $307K in Q1 2023.
923 funds tracked by Wall St. Rank held Labcorp as of Q4 2024.

Based on Maven Securities's 13F filing for Q4 2024, filed 14 Feb 2025.